AU2016265839A1 - Methods of discriminating between HIV-1 and lentiviral vectors - Google Patents
Methods of discriminating between HIV-1 and lentiviral vectors Download PDFInfo
- Publication number
- AU2016265839A1 AU2016265839A1 AU2016265839A AU2016265839A AU2016265839A1 AU 2016265839 A1 AU2016265839 A1 AU 2016265839A1 AU 2016265839 A AU2016265839 A AU 2016265839A AU 2016265839 A AU2016265839 A AU 2016265839A AU 2016265839 A1 AU2016265839 A1 AU 2016265839A1
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acid
- hiv
- sequence
- seq
- probe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562163327P | 2015-05-18 | 2015-05-18 | |
| US62/163,327 | 2015-05-18 | ||
| PCT/US2016/032767 WO2016187151A1 (en) | 2015-05-18 | 2016-05-16 | Methods of discriminating between hiv-1 and lentiviral vectors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2016265839A1 true AU2016265839A1 (en) | 2017-12-07 |
Family
ID=56121165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016265839A Abandoned AU2016265839A1 (en) | 2015-05-18 | 2016-05-16 | Methods of discriminating between HIV-1 and lentiviral vectors |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10240214B2 (enExample) |
| EP (1) | EP3283658B1 (enExample) |
| JP (1) | JP2018516594A (enExample) |
| CN (1) | CN108026593A (enExample) |
| AU (1) | AU2016265839A1 (enExample) |
| CA (1) | CA2986133A1 (enExample) |
| DK (1) | DK3283658T3 (enExample) |
| ES (1) | ES2784351T3 (enExample) |
| HK (1) | HK1247965A1 (enExample) |
| WO (1) | WO2016187151A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12612654B2 (en) * | 2016-02-12 | 2026-04-28 | CureVac SE | Method for analyzing RNA |
| EP3423595A1 (en) | 2016-03-03 | 2019-01-09 | CureVac AG | Rna analysis by total hydrolysis |
| CN115768899B (zh) * | 2020-03-09 | 2026-03-27 | 詹森生物科技公司 | 用于定量重组载体核酸整合的组合物和方法 |
| CN111961760A (zh) * | 2020-09-02 | 2020-11-20 | 苏州市第五人民医院 | 基于ddPCR自动化检测HIV-1的引物组、探针组、试剂盒及用途 |
| CN114134251B (zh) * | 2020-09-04 | 2025-04-01 | 上海赛比曼生物科技有限公司 | 一种快速检测慢病毒载体滴度的方法 |
| CN112210625A (zh) * | 2020-11-02 | 2021-01-12 | 中山大学达安基因股份有限公司 | 定量检测人类免疫缺陷病毒1型dna载量的试剂盒及方法 |
| CN113151587A (zh) * | 2021-01-28 | 2021-07-23 | 云舟生物科技（广州）有限公司 | 一种慢病毒滴度检测引物、试剂盒及检测方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4000159A (en) | 1974-06-28 | 1976-12-28 | Phillips Petroleum Company | Preparation of n,n-disubstituted thioamides |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US5176995A (en) | 1985-03-28 | 1993-01-05 | Hoffmann-La Roche Inc. | Detection of viruses by amplification and hybridization |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| WO1991001384A1 (en) * | 1989-07-11 | 1991-02-07 | Gen-Probe, Incorporated | Nucleic acid sequence amplification methods utilizing a transcription complex |
| WO1992020813A1 (en) * | 1991-05-17 | 1992-11-26 | Dana Farber Cancer Institute | Assays for factors affecting circularization of dna, assays for factors affecting dna integration, factors, and uses thereof |
| US5578444A (en) * | 1991-06-27 | 1996-11-26 | Genelabs Technologies, Inc. | Sequence-directed DNA-binding molecules compositions and methods |
| US5576176A (en) * | 1994-03-03 | 1996-11-19 | The Regents Of The University Of California | Marker and an assay for detection and monitoring of human immunodeficiency virus latency and activation |
| US20030104576A1 (en) * | 1994-10-07 | 2003-06-05 | Jonathan W. Nyce | Dna construct, composition, formulations & methods for making the construct & for modulating expression |
| DE19907485B4 (de) * | 1999-02-12 | 2008-01-17 | Strathmann Ag & Co. | Virus-Vakzine |
| JP5122957B2 (ja) * | 2005-08-16 | 2013-01-16 | タカラバイオ株式会社 | 免疫不全ウイルス感染症の治療または予防のための核酸 |
| US20120201794A1 (en) * | 2009-07-15 | 2012-08-09 | Calimmune Inc. | Dual vector for inhibition of human immunodeficiency virus |
| EP2456786B2 (en) | 2009-07-24 | 2017-04-19 | Immune Design Corp | Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein |
| NZ616304A (en) * | 2011-04-08 | 2016-01-29 | Immune Design Corp | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses |
| JP2015524670A (ja) * | 2012-08-16 | 2015-08-27 | エヌブイエス テクノロジーズ，インコーポレイティド | アッセイ方法及び系 |
| CN103882062A (zh) * | 2014-03-13 | 2014-06-25 | 山西大学 | 慢病毒干扰载体pll3.7-Neo及其构建方法 |
-
2016
- 2016-05-16 CN CN201680042304.1A patent/CN108026593A/zh active Pending
- 2016-05-16 AU AU2016265839A patent/AU2016265839A1/en not_active Abandoned
- 2016-05-16 WO PCT/US2016/032767 patent/WO2016187151A1/en not_active Ceased
- 2016-05-16 CA CA2986133A patent/CA2986133A1/en not_active Abandoned
- 2016-05-16 EP EP16729099.8A patent/EP3283658B1/en active Active
- 2016-05-16 JP JP2018512815A patent/JP2018516594A/ja active Pending
- 2016-05-16 HK HK18107366.1A patent/HK1247965A1/zh unknown
- 2016-05-16 ES ES16729099T patent/ES2784351T3/es active Active
- 2016-05-16 DK DK16729099.8T patent/DK3283658T3/da active
-
2017
- 2017-11-13 US US15/810,254 patent/US10240214B2/en not_active Expired - Fee Related
-
2019
- 2019-02-05 US US16/267,404 patent/US11008630B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018516594A (ja) | 2018-06-28 |
| US11008630B2 (en) | 2021-05-18 |
| DK3283658T3 (da) | 2020-05-18 |
| US10240214B2 (en) | 2019-03-26 |
| EP3283658A1 (en) | 2018-02-21 |
| EP3283658B1 (en) | 2020-03-11 |
| CA2986133A1 (en) | 2016-11-24 |
| HK1247965A1 (zh) | 2018-10-05 |
| ES2784351T3 (es) | 2020-09-24 |
| US20190153551A1 (en) | 2019-05-23 |
| WO2016187151A1 (en) | 2016-11-24 |
| US20180066325A1 (en) | 2018-03-08 |
| CN108026593A (zh) | 2018-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11008630B2 (en) | Methods for discriminating between HIV-1 and lentiviral vectors | |
| CA2295920C (en) | Oligonucleotide reverse transcription primers for efficient detection of hiv-1 and hiv-2 and methods of use thereof | |
| JP7512362B2 (ja) | レンチウイルスを検出する方法 | |
| JP4413610B2 (ja) | Ｈｉｖ−１の増幅及び検出試薬 | |
| JP2004532027A (ja) | ユニバーサルマルチ変異体検出システム | |
| WO2013111800A1 (ja) | Ｈｉｖ検出用オリゴヌクレオチド、ｈｉｖ検出キット、及びｈｉｖ検出方法 | |
| EP1960554B1 (en) | Methods, plasmid vectors and primers for assessing hiv viral fitness | |
| US8575324B2 (en) | Methods and reagents for molecular detection of HIV-1 groups M, N and O | |
| JP4913042B2 (ja) | Ｈｉｖタイプおよびサブタイプの検出 | |
| KR102722347B1 (ko) | 유전자가위 기반 중증열성혈소판감소증후군 바이러스의 신속 검출 | |
| JP2007135469A (ja) | 核酸増幅方法 | |
| CA3035808C (en) | Methods of detecting lentivirus | |
| WO2005061735A2 (en) | Strand-specific amplification | |
| WO2002031204A2 (en) | Assay to detect integration of a retrovirus polynucleotide into a target nucleic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HB | Alteration of name in register |
Owner name: ST. VINCENT'S HOSPITAL SYDNEY Free format text: FORMER NAME(S): CALIMMUNE INC. ; CALIMMUNE AUSTRALIA PTY LTD; ST. VINCENT'S HOSPITAL SYDNEY; NEWSOUTH INNOVATIONS PTY LIMITED Owner name: CSL BEHRING GENE THERAPY, INC. Free format text: FORMER NAME(S): CALIMMUNE INC. ; CALIMMUNE AUSTRALIA PTY LTD; ST. VINCENT'S HOSPITAL SYDNEY; NEWSOUTH INNOVATIONS PTY LIMITED Owner name: CALIMMUNE AUSTRALIA PTY LTD Free format text: FORMER NAME(S): CALIMMUNE INC. ; CALIMMUNE AUSTRALIA PTY LTD; ST. VINCENT'S HOSPITAL SYDNEY; NEWSOUTH INNOVATIONS PTY LIMITED Owner name: NEWSOUTH INNOVATIONS PTY LIMITED Free format text: FORMER NAME(S): CALIMMUNE INC. ; CALIMMUNE AUSTRALIA PTY LTD; ST. VINCENT'S HOSPITAL SYDNEY; NEWSOUTH INNOVATIONS PTY LIMITED |
|
| HB | Alteration of name in register |
Owner name: CSL GENE THERAPY PTY LTD Free format text: FORMER NAME(S): CSL BEHRING GENE THERAPY, INC.; ST. VINCENT'S HOSPITAL SYDNEY; NEWSOUTH INNOVATIONS PTY LIMITED; CALIMMUNE AUSTRALIA PTY LTD Owner name: ST. VINCENT'S HOSPITAL SYDNEY Free format text: FORMER NAME(S): CSL BEHRING GENE THERAPY, INC.; ST. VINCENT'S HOSPITAL SYDNEY; NEWSOUTH INNOVATIONS PTY LIMITED; CALIMMUNE AUSTRALIA PTY LTD Owner name: CSL BEHRING GENE THERAPY, INC. Free format text: FORMER NAME(S): CSL BEHRING GENE THERAPY, INC.; ST. VINCENT'S HOSPITAL SYDNEY; NEWSOUTH INNOVATIONS PTY LIMITED; CALIMMUNE AUSTRALIA PTY LTD Owner name: NEWSOUTH INNOVATIONS PTY LIMITED Free format text: FORMER NAME(S): CSL BEHRING GENE THERAPY, INC.; ST. VINCENT'S HOSPITAL SYDNEY; NEWSOUTH INNOVATIONS PTY LIMITED; CALIMMUNE AUSTRALIA PTY LTD |
|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |